CLAL Biotechnology Industries Ltd. Logo

CLAL Biotechnology Industries Ltd.

A life sciences VC firm financing and supporting innovative biotech & healthcare ventures.

CBI | TA

Overview

Corporate Details

ISIN(s):
IL0011042806
LEI:
Country:
Israel
Address:
Triangle Building 45th flr., 67023 Tel Aviv
Sector:
Financial and insurance activities
Industry:
Activities of trusts, funds and similar financial entities

Description

Clal Biotechnology Industries Ltd. (CBI) is a leading life sciences investment company and venture capital firm founded in 1998. CBI specializes in identifying, financing, and supporting innovative ventures within the biotechnology and healthcare sectors. Its investment strategy focuses on biopharmaceutical, diagnostic, and medical device companies that develop proprietary solutions to address significant unmet medical needs with high market potential. The firm actively manages its portfolio companies, providing strategic support to foster their growth from early-stage development through to commercialization.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-01-08 10:01
Investor Presentation
Corporate Presentation, January 2023
English 3.1 MB
2023-01-08 10:01
Regulatory Filings
Corporate Presentation, January 2023
Russian 41.8 KB
2021-02-14 15:58
Investor Presentation
CBI-Presentation-February 2021
English 2.4 MB
2021-02-14 15:58
Pre-Annual General Meeting Information
CBI-Presentation-February 2021
Russian 43.2 KB
2020-11-22 11:19
Investor Presentation
INVESTORS PRESENTATION,NOVEMBER 10,2020
English 1.9 MB
2020-11-22 11:19
AGM Information
INVESTORS PRESENTATION,NOVEMBER 10,2020
Russian 43.3 KB
2020-08-24 11:54
Investor Presentation
CORPORATE PRESENTATION AUGUST 2020
English 1.7 MB
2020-08-24 11:54
Regulatory Filings
CORPORATE PRESENTATION AUGUST 2020
Russian 43.2 KB

Automate Your Workflow. Get a real-time feed of all CLAL Biotechnology Industries Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CLAL Biotechnology Industries Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CLAL Biotechnology Industries Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

INVESCO ASIA TRUST PLC Logo
Investment trust targeting capital growth from a portfolio of Asian & Australasian equities.
United States of America
IAT
Invesco Bond Fund Logo
An investment fund providing interest income and capital preservation via a diversified bond portfolio.
United States of America
VBF
INVESCO BOND INCOME PLUS LIMITED Logo
Invests in global high-yield bonds and securities for high income and capital growth.
United States of America
BIPS
Invesco California Value Municipal Income Trust Logo
A fund investing in California municipal securities for federal & CA tax-exempt income.
United States of America
VCV
An ETF that tracks the Australian dollar's value relative to the U.S. dollar for investors.
United States of America
FXA
An ETF tracking the British pound's performance against the U.S. dollar for investors.
United States of America
FXB
An ETF that tracks the Canadian dollar's price against the U.S. dollar for investors.
United States of America
FXC
An ETF tracking the euro's price against the U.S. dollar for retail and institutional investors.
United States of America
FXE
An ETF tracking the Japanese yen's price, offering investors accessible currency exposure.
United States of America
FXY
An ETF tracking the Swiss franc's price against the U.S. dollar for investors.
United States of America
FXF

Talk to a Data Expert

Have a question? We'll get back to you promptly.